首页> 外文期刊>Research and practice in thrombosis and haemostasis. >Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability
【24h】

Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability

机译:在健康成年人群中使用ST Genesia凝血酶生成系统测量凝血酶生成:正常值和变异性

获取原文
           

摘要

Background Thrombin generation (TG) assays evaluate the balance between pro‐ and anticoagulant forces, to better assess bleeding and thrombotic risks. Although TG readouts obtained with the calibrated automated TG have been investigated in multiple clinical conditions, TG still needs standardization and clinical validation. The automated TG instrument ST Genesia? (STG, Stago, Asnières‐sur‐Seine, France) provides a normalization of TG parameters based on a reference plasma aiming to reduce the interlaboratory variability and the variability between different measurement runs. Objectives To evaluate STG in a group of healthy adults. Methods Reference intervals in healthy adults and variability of the new standardized reagents for bleeding (BleedScreen) and thrombophilic (ThromboScreen) conditions were determined using STG. Results TG was measured in platelet‐free plasma (PFP) samples of 123 healthy adults. Reference intervals were determined for TG parameters. Intra‐ and interassay coefficients of variation were calculated on quality controls and PFP samples from healthy adults. Oral contraception (OC) possibly influenced TG parameters, resulting in a higher median and a broader reference interval for peak height and endogenous thrombin potential (ETP) in women aged 20 to 49?years than in all other sex and age categories. Therefore, we propose the following reference interval categories: men, women aged 50?years not using OC, women aged 50 years using OC, and women aged ≥50?years. Normalization was effective to reduce the interassay variability of quality controls for ETP (BleedScreen assay), and peak height and ETP (ThromboScreen assay without thrombomodulin), but had little impact on PFP sample variability. Conclusion STG appears suitable for accurate measurement of TG in healthy adults.
机译:背景凝血酶生成(TG)分析可评估促凝和抗凝作用力之间的平衡,以更好地评估出血和血栓形成的风险。尽管已在多种临床条件下研究了使用校准的自动TG获得的TG读数,但TG仍需要标准化和临床验证。自动化TG仪器ST Genesia? (STG,位于法国塞纳河畔阿斯涅尔的Stago)提供了基于参考血浆的TG参数归一化功能,旨在减少实验室间的变异性和不同测量运行之间的变异性。目的评估一组健康成年人的STG。方法使用STG测定健康成年人的参考间隔和出血(BleedScreen)和血栓形成性(ThromboScreen)新标准试剂的变异性。结果在123名健康成年人的无血小板血浆(PFP)样本中测量了TG。确定TG参数的参考间隔。批内和批间变异系数是根据健康成年人的质量控制和PFP样本计算得出的。口服避孕药(OC)可能会影响TG参数,与所有其他性别和年龄类别相比,导致20至49岁女性的峰值高度和内源性凝血酶潜能(ETP)更高的中位数和更大的参考区间。因此,我们提出以下参考区间类别:男性,年龄小于50岁的女性不使用OC,年龄小于50岁的女性不使用OC和年龄大于或等于50岁的女性。归一化可有效减少ETP(BleedScreen测定),峰高和ETP(无血栓调节蛋白的ThromboScreen测定)质控品的测定间变异性,但对PFP样品变异性影响很小。结论STG似乎适合准确测量健康成年人的TG。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号